Research Article
BibTex RIS Cite

COVID-19 pandemic: depression and sleep quality in hemodialysis patients

Year 2022, Volume: 5 Issue: 2, 573 - 578, 15.03.2022
https://doi.org/10.32322/jhsm.1054899

Abstract

Introduction: Depression and sleep disturbance are prevalent comorbidities in hemodialysis patients. This study aimed to investigate the relationship between depressive mood, sleep disturbance, and the fear of COVID-19 Scale in hemodialysis patients during the pandemic process.
Material and Method: 116 hemodialysis patients followed up in our clinic and volunteered were included in the study. The socio-demographic characteristics of the patients and the laboratory test results studied in their routine follow-ups were obtained from the file records. Beck Depression Inventory (BDI), Pittsburgh Sleep Quality Index (PSQI), and the Fear of COVID-19 Scale (FCV-19S) were applied through face-to-face interviews.
Results: 116 patients (70 males, 46 females) with a hemodialysis duration of 40 months (13-295) and age of 60.2±13.3 years were included in the study. The patients were divided into two groups according to their PSQI score as good sleeper (PSQI ≤ 5, n=66) and poor sleeper (PSQI >5, n=50). When evaluated by gender 28 (56%) female patients were in the poor sleeper group (p=0.002). Dialysis time was longer, BDI score and FCV-19 scale were higher in the poor sleeper group than the good sleeper group. PSQI score was positively correlated with dialysis time (r=0.259 p=0.005), BDI score (r=0.279 p=0.002), and FCV-19 scale (r=0.304 p=0.001). In the Multiple Logistic Regression analysis established to evaluate the risk factors affecting sleep quality, BDI was determined as an independent risk factor for poor sleep (OR: 1.084, 95%CI [1.021-1.152], p=0.008). Subjects were divided into two groups according to their BDI scores as those with depressive mood (BDI score ≥ 17, n=47) (40.5%) and those without (BDI score < 17, n=69) (59.5%). Thirty-two of the cases with depressive mood were women (68.1%) (p<0.001). There was a female predominance in the depressed patient group. The economic status was worse in the depressed group compared to the non-depressed group, and the PSQI score and FVC-19 scale were higher. In addition, BDI score was positively correlated with age (r=0.225 p =0.015), female gender (r=0.473 p=0.001), poor economic status (r=0.576 p =0.001), FVC-19 scale (r=0.330 p =0.001), while negatively correlated with serum albumin level (r=-0.279 p=0.003) and serum creatinine level (r=-0.2455 p =0.008). In the Multiple Logistic Regression model established, female gender (OR: 7.857, 95%CI [2.463-25.065], p<0.001) and poor economic status (OR: 7.569, 95%CI [2,300-24,908], p=0.001) were determined as independent risk factors for depressive mood.
Conclusion: Nearly half of the patients had sleep disorders and depressive mood. Patients in the depressive mood and poor sleep group had a higher FVC-19 scale. We think it would be beneficial not to ignore the increased frequency of depressive mood and sleep disorders in hemodialysis patients during the COVID-19 pandemic.

References

  • Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int 2020; 97: 824–8.
  • Xiang Y T, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 2020; 7: 228–9.
  • Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62: 199–207.
  • Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003; 41: 105–10.
  • Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int 2015; 88: 447–59.
  • Elder SJ, Pisoni RL, Akizawa T, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008; 23: 998–1004.
  • Lindner AV, Novak M, Bohra M, Mucsi I. Insomnia in patients with chronic kidney disease. Semin Nephrol 2015; 35: 359–72.
  • Ikizler TA. COVID-19 and dialysis units: what do we know now and what should we do? Am J Kidney Dis 2020; 76: 1–3.
  • Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review Psychopathology 1998; 31: 160-8.
  • Hisli N. Beck Depresyon Envanteri’nin geçerliliği üzerine bir çalışma. Psikoloji Derg 1998; 6: 118–22.
  • Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. Pittsburgh Uyku Kalitesi İndeksi: Psikiyatrik uygulama ve araştırma için yeni bir araç. Psikiyatri Araş 1989; 28 : 193–213.
  • Ladikli N, Bahadır E, Yumusak F, Akkuzu H, Karaman G, Turkkan Z. Uluslararası Sosyal Bilimler Derg 2020; 3: 71-80.
  • Malta M, Rimoin AW, Strathdee SA. The coronavirus 2019-nCoV epidemic: is hindsight 20/20? E Clin Med 2020; 20: 100289.
  • Ornell F, Schuch BJ, Sordi AO, Kessler FHP. Pandemic fear" and COVID-19: mental health burden and strategies. Braz J Psychiatry 2020; 42: 232-5.
  • Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci 2020; 74: 281-2.
  • Cohen LM, Dobscha SK, Hails KC, et al. Depression and suicidal ideation in patients who discontinue the life-support treatment of dialysis. Psychosom Med 2002; 64: 889–96.
  • Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K. Depression on dialysis. Nephron Clin Pract 2008; 108: 256-64.
  • Chen CK , Tsai YC, Hsu HJ, et al. Depression and suicide risk in hemodialysis patients with chronic renal failure Psychosomatics Nov-Dec 2010; 51: 528.
  • Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–20.
  • Umucu E, Lee B. Examining the impact of COVID-19 on stress and coping strategies in individuals with disabilities and chronic conditions. Rehabil Psychol 2020; 65: 193–8.
  • Naamani AZ, Gormley K, Noble H, Santin O, Maqbali MA. Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. BMC Nephrol 2021; 22: 157.
  • Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21: 184–90.
  • Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 2007; 17: 381-8.
  • Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res 2020; 288: 112954.
  • Gamaldo CE, Shaikh AK, McArthur JC. The sleep-immunity relationship. Neurol Clin 2012; 30: 1313–43.
  • Xiao H, Zhang Y, Kong D. Social Capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020; 26: 921–3.
  • Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiatr 2020; 66: 504–11.
  • Koch BC, Nagtegaal JE, Hagen EC, et al. The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, crossover study (EMSCAP study) Br J Clin Pharmacol 2009; 67: 68–75.
  • Dhabhar F.S. Enhancing versus suppressive effects of stres on immune function: implications for immunoprotection and immunpathology. Neuroimmunomodulation 2009; 16: 300–317.
  • Akbulut H, İçli F, Büyükçelik A. The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatoninin the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer. J Pineal Res 1999; 26: 1–8.
  • Akıncı T , Başar HM. Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19 Sleep Med 2021; 80: 167-70.
Year 2022, Volume: 5 Issue: 2, 573 - 578, 15.03.2022
https://doi.org/10.32322/jhsm.1054899

Abstract

References

  • Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The novel coronavirus 2019 epidemic and kidneys. Kidney Int 2020; 97: 824–8.
  • Xiang Y T, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 2020; 7: 228–9.
  • Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 2002; 62: 199–207.
  • Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003; 41: 105–10.
  • Davison SN, Levin A, Moss AH, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int 2015; 88: 447–59.
  • Elder SJ, Pisoni RL, Akizawa T, et al. Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008; 23: 998–1004.
  • Lindner AV, Novak M, Bohra M, Mucsi I. Insomnia in patients with chronic kidney disease. Semin Nephrol 2015; 35: 359–72.
  • Ikizler TA. COVID-19 and dialysis units: what do we know now and what should we do? Am J Kidney Dis 2020; 76: 1–3.
  • Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review Psychopathology 1998; 31: 160-8.
  • Hisli N. Beck Depresyon Envanteri’nin geçerliliği üzerine bir çalışma. Psikoloji Derg 1998; 6: 118–22.
  • Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. Pittsburgh Uyku Kalitesi İndeksi: Psikiyatrik uygulama ve araştırma için yeni bir araç. Psikiyatri Araş 1989; 28 : 193–213.
  • Ladikli N, Bahadır E, Yumusak F, Akkuzu H, Karaman G, Turkkan Z. Uluslararası Sosyal Bilimler Derg 2020; 3: 71-80.
  • Malta M, Rimoin AW, Strathdee SA. The coronavirus 2019-nCoV epidemic: is hindsight 20/20? E Clin Med 2020; 20: 100289.
  • Ornell F, Schuch BJ, Sordi AO, Kessler FHP. Pandemic fear" and COVID-19: mental health burden and strategies. Braz J Psychiatry 2020; 42: 232-5.
  • Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M, Benedek DM. Public responses to the novel 2019 coronavirus (2019-nCoV) in Japan: mental health consequences and target populations. Psychiatry Clin Neurosci 2020; 74: 281-2.
  • Cohen LM, Dobscha SK, Hails KC, et al. Depression and suicidal ideation in patients who discontinue the life-support treatment of dialysis. Psychosom Med 2002; 64: 889–96.
  • Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K. Depression on dialysis. Nephron Clin Pract 2008; 108: 256-64.
  • Chen CK , Tsai YC, Hsu HJ, et al. Depression and suicide risk in hemodialysis patients with chronic renal failure Psychosomatics Nov-Dec 2010; 51: 528.
  • Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020; 395: 912–20.
  • Umucu E, Lee B. Examining the impact of COVID-19 on stress and coping strategies in individuals with disabilities and chronic conditions. Rehabil Psychol 2020; 65: 193–8.
  • Naamani AZ, Gormley K, Noble H, Santin O, Maqbali MA. Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. BMC Nephrol 2021; 22: 157.
  • Merlino G, Piani A, Dolso P, et al. Sleep disorders in patients with end stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant 2006; 21: 184–90.
  • Bilgic A, Akgul A, Sezer S, Arat Z, Ozdemir FN, Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J Ren Nutr 2007; 17: 381-8.
  • Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res 2020; 288: 112954.
  • Gamaldo CE, Shaikh AK, McArthur JC. The sleep-immunity relationship. Neurol Clin 2012; 30: 1313–43.
  • Xiao H, Zhang Y, Kong D. Social Capital and sleep quality in individuals who self-isolated for 14 days during the coronavirus disease 2019 (COVID-19) outbreak in January 2020 in China. Med Sci Monit 2020; 26: 921–3.
  • Özdin S, Bayrak Özdin Ş. Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender. Int J Soc Psychiatr 2020; 66: 504–11.
  • Koch BC, Nagtegaal JE, Hagen EC, et al. The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, crossover study (EMSCAP study) Br J Clin Pharmacol 2009; 67: 68–75.
  • Dhabhar F.S. Enhancing versus suppressive effects of stres on immune function: implications for immunoprotection and immunpathology. Neuroimmunomodulation 2009; 16: 300–317.
  • Akbulut H, İçli F, Büyükçelik A. The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatoninin the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer. J Pineal Res 1999; 26: 1–8.
  • Akıncı T , Başar HM. Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19 Sleep Med 2021; 80: 167-70.
There are 31 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Original Article
Authors

Demet Yavuz 0000-0002-4082-6320

Ayşe Pınar Doğru Balakbabalar 0000-0002-9305-5013

Mehmet Derya Demirag

Siren Sezer

Publication Date March 15, 2022
Published in Issue Year 2022 Volume: 5 Issue: 2

Cite

AMA Yavuz D, Doğru Balakbabalar AP, Demirag MD, Sezer S. COVID-19 pandemic: depression and sleep quality in hemodialysis patients. J Health Sci Med / JHSM. March 2022;5(2):573-578. doi:10.32322/jhsm.1054899

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912


Editor List for 2022

Assoc. Prof. Alpaslan TANOĞLU (MD)  

Prof. Aydın ÇİFCİ (MD)

Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)

Prof. Murat KEKİLLİ (MD)

Prof. Yavuz BEYAZIT (MD) 

Prof. Ekrem ÜNAL (MD)

Prof. Ahmet EKEN (MD)

Assoc. Prof. Ercan YUVANÇ (MD)

Assoc. Prof. Bekir UÇAN (MD) 

Assoc. Prof. Mehmet Sinan DAL (MD)


Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.